Published in
Impact Journals, Oncotarget, 49(10), p. 5011-5019, 2019
DOI: 10.18632/oncotarget.27082
Links
Tools
TAK228 enhances antitumor activity of eribulin in triple negative breast cancer
Journal article published in 2019 by
Nicci Owusu-Brackett,
Kurt W. Evans,
Heidi L. Kenerson,
Argun Akcakanat 
,
Erkan Yuca,
Kevin M. Riggle,
Rigney Turnham,
Coya Tapia,
Kevin Sullivan,
Yasmeen Qamar Rizvi,
Renay Bauer,
Ecaterina Ileana Dumbrava,
John D. Scott,
Filip Janku,
Funda Meric-Bernstam
and other authors.
,
Erkan Yuca,
Kevin M. Riggle,
Rigney Turnham,
Coya Tapia,
Kevin Sullivan,
Yasmeen Qamar Rizvi,
Renay Bauer,
Ecaterina Ileana Dumbrava,
John D. Scott,
Filip Janku,
Funda Meric-Bernstam
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 